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Abstract
Objective: Late outcome after mitral valve repair was examined to define preoperative predictors of recurrent atrial fibrillation late after
successful mitral valve reconstruction. Methods: One hundred and eighty-nine patients, 112 with preoperative sinus rhythm and 72 with
preoperative chronic or intermittent atrial fibrillation, were followed for 12.2 – 10 years after valve repair. Clinic, hemodynamic end
echocardiographic data were entered into Cox-regression and Kaplan–Meyer analysis to assess predictors for recurrent atrial fibrillation
late after successful mitral valve repair. Results: Univariate and multivariate predictors for recurrent atrial fibrillation late after successful
mitral valve reconstruction were preoperative atrial fibrillation (P = 0.0001), preoperative antiarrhythmic drug treatment (P = 0.005), heart
rate (P = 0.01), left ventricular ejection fraction (P = 0.01) and increased left ventricular posterior wall thickness (P = 0.05). Patients
. 57.5 years with a mean pulmonary artery pressure ‡ 23mm Hg and a history of preoperative antiarrhythmic drug treatment had an odds
ratio of 53.33 (95% confidence limits 6.12–464.54) for atrial fibrillation late after successful mitral valve repair. Conclusion: Older patients
with a history of atrial fibrillation, antiarrhythmic treatment or an elevated pulmonary artery pressure may present atrial fibrillation late after
successful mitral valve repair. They could be considered for combined mitral valve reconstruction and surgery for atrial fibrillation even
though sinus rhythm is present preoperatively. Ó 1998 Elsevier Science B.V. All rights reserved
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1. Introduction
Atrial fibrillation is the most common heart rhythm dis-
turbance and results in significant cardiovascular and cere-
brovascular mortality and morbidity [1]. The prevalence of
atrial fibrillation is variable ranging up to 75% in patients
with severe mitral valve regurgitation [2]. Surgery for atrial
fibrillation – such as the maze procedure – may be effective
in restoring normal sinus rhythm in patients with chronic
atrial fibrillation [3] and has been found to be an ideal com-
plement to reconstructive mitral valve surgery since long
lasting atrial fibrillation rarely converts to normal sinus
rhythm after mitral valve surgery [4]. Although surgery
for atrial fibrillation can be combined with mitral valve
surgery without adding undue operative risks [5], there
may be – e.g. in the setting of a maze procedure – a sig-
nificant requirement for postoperative pacemaker implanta-
tion [3]. In addition, multiple incisions in the atrial wall may
cause delayed improvement in exercise capacity [6] or a
temporary loss of cardiac autonomic innervation [7].
Thus, the decision to combine reconstructive mitral valve
surgery with surgery for atrial fibrillation should be based
on the knowledge of the heart rhythm late after mitral valve
repair to identify those patients who presumably will benefit
from this more invasive approach.
Therefore, we undertook the present retrospective study
to define preoperative predictors for recurrent chronic or
intermittent atrial fibrillation late after successful mitral
valve repair.
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2. Materials and methods
2.1. Patients
All medical and surgical data were recorded from patients
who had primary, isolated mitral valve repair between 1976
and 1994 at the Division of Cardiovascular Surgery, Uni-
versity Hospital, Zurich. Follow-up information was
obtained by direct contact with the patients and the primary
care physician.
The study group consisted in 189 patients, 121 (64%)
men and 68 (36%) women. The mean age at operation
was 56 – 14 years. Indication for the operation was pure
mitral valve regurgitation in 156 patients (83%), mitral
valve stenosis in 16 (8%) and combined mitral valve disease
in 17 patients (9%). Preoperatively, sinus rhythm was found
in 112 patients (59%), chronic atrial fibrillation in 49 (26%)
and documented intermittent atrial fibrillation in 28 (15%).
The mean preoperative duration of atrial fibrillation was 43
months (range, 1 months to 9.5 years). Digoxin, the most
frequently used preoperative antiarrhythmic drug, was pre-
scribed in 108 patients (57%), whereas 99 (52%) had var-
ious other antiarrhythmic drugs prior to mitral valve repair.
The associated cardiovascular co-morbidity was low:
hypertension was present in 38 patients (20%), coronary
artery disease in 15 (8%) and insulin-dependent diabetes
mellitus in seven (4%).
Preoperative echocardiographic and hemodynamic data
are summarised in Table 1. End systolic and end diastolic
left ventricular dimensions, measured by echocardiography,
as well as left ventricular posterior wall thickness have been
obtained in 80% of patients only.
Patients with residual or recurrent mitral valve regurgita-
tion ‡ grade 2, reoperative cardiac-thoracic surgery during
follow-up and those who were in the New York Heart Asso-
ciation class III and IV, were excluded from this study. Only
patients with complete data and a documented electrocar-
diographic study at the end of follow-up were analysed.
Fifteen percent of patients operated during the study period
were lost to follow-up. The mean follow-up time of the
study was 12.2 – 10 years, with a median follow-up of 11
years.
2.2. Operative technique
A median sternotomy was performed in all patients. Stan-
dard cardiopulmonary bypass was used either with a single
two-stage cannula in the right atrium or with bicaval can-
nulation. Ventricular fibrillation was induced and the left
atrium was then opened dorsally and perpendicular to the
Waterstone line to assess mitral valve pathology. If techni-
cally feasible, the mitral valve was repaired during induced
ventricular fibrillation. Otherwise, the aorta was cross-
clamped and the heart arrested using antegrade, and in
recent years combined antegrade-retrograde cardioplegia.
The mitral valve was reconstructed using standard Carpen-
tier’s technique [8,9]. The left atrium was closed with a non-
absorbable running polypropylene suture. Surgery in the left
atrial appendage, usually a silk ligature around its broad
base, has been performed inconsistently and, therefore,
has not been evaluated as a preoperative predictor for late
atrial fibrillation. De-airing, weaning from cardiopulmon-
ary, decannulation and chest closure were conducted in
the usual manner.
2.3. Statistical analysis
Descriptive statistics are expressed as means – S.D. Step-
wise logistic regression was used to analyse preoperative
predictors for atrial fibrillation at the end of follow-up. The
Cox regression determined hazard ratios for episodes of
atrial fibrillation during the follow-up period, regardless of
the heart rhythm found at the end of the follow-up period.
Preoperative predictors were analysed for all patients and for
those with preoperative atrial fibrillation. A linear regression
model was used to define preoperative cut-off points for
recurrence of postoperative atrial fibrillation. Values of
P , 0.05 were considered to be of statistical significance.
All calculation were performed using a commercially avail-
able statistical package (SPSS for Windows 6.0).
3. Results
3.1. Preoperative predictors for late atrial fibrillation: all
patients (Tables 2 and 3)
The presence of preoperative chronic or intermittent
atrial fibrillation (P = 0.0001), older age at operation
(P = 0.005) and increased heart rate (P = 0.05) were the
Table 1
Preoperative hemodynamic and echocardiographic data in patients under-
going isolated reconstructive mitral valve surgery
Preoperative heart rate (beats/min) 78.5 – 16.5
Left atrial dimension (cm) 5.2 – 1.1 (range 2.6–9.2)
LVEDD (cm) 6.4 – 1.1
LVESD (cm) 4.0 – 0.8
Ventricular septal wall thickness (mm) 10.2 – 2.2
Left ventricular posterior
wall thickness (mm)
9.3 – 2.5
LFEF (%) 63.5 – 11
LVEDP (mmHg) 13.7 – 7.3
Wedge-pressure (mmHg) 16.1 – 8.0
Cardiac index (l/min) 2.7 – 0.7
PAPS (mmHg) 39 – 18.7
PAPD (mmHg) 15.9 – 9.3
Mean PAP (mmHg) 25.8 – 13.6
LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular
end-systolic dimensions; LFEF, left ventricular ejection fraction; LVEDP,
left ventricular end-diastolic pressure; PAPS, systolic pulmonary artery
pressure; PAPD, diastolic pulmonary artery pressure; PAP, pulmonary
artery pressure.
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strongest predictor for atrial fibrillation late after mitral
valve surgery, in univariate as well as in multivariate ana-
lysis.
To give an example, a 60-year-old patient has a 1.0510
higher risk for late atrial fibrillation than a 50-year-old,
whereas a 75-year-old patient would have a 1.0525 higher
risk to be in late atrial fibrillation compared to the 50-year-
old. Accordingly, a patient with a 48-month history of atrial
fibrillation prior to mitral valve surgery has a 1.0436higher
risk to be in atrial fibrillation late after mitral valve repair
than a patient with a 12-month history of preoperative atrial
fibrillation.
A history of preoperative digoxin medication had nearly a
threefold risk for late atrial fibrillation although this was not
an independent predictor (P = 0.001). Surprisingly, an
increased left atrial diameter, longer preoperative duration
of atrial fibrillation and a reduced left ventricular ejection
fraction were not found to be independent predictors.
3.2. Preoperative predictors for late atrial fibrillation:
patients with atrial fibrillation prior to mitral valve repair
(Tables 4 and 5)
For patients with preoperative atrial fibrillation, increased
mean pulmonary artery pressure (P = 0.05), older age at
operation (P = 0.05) and a history of chronic versus inter-
mittent atrial fibrillation prior to mitral valve repair (P =
0.05) were the most important predictors for atrial fibrilla-
tion late after successful mitral valve reconstruction. A his-
tory of preoperative antiarrhythmic drug treatment had a
fourfold risk to be in late atrial fibrillation although it was
not an independent predictor.
3.3. Preoperative predictors for episodes of atrial
fibrillation during the follow-up period: all patients (Tables
6 and 7)
The lack of preoperative sinus rhythm (P = 0.0001),
increased left atrial diameter (P = 0.005), decreased left
ventricular ejection fraction (P = 0.01) and older age at
operation (P = 0.05) were independent predictors for recur-
rent episodes of atrial fibrillation during the follow-up per-
iod. Longer duration of atrial fibrillation prior to surgery and
increased left ventricular end-systolic diameter were found
to be significant predictors only in univariate analysis.
3.4. Preoperative predictors for episodes of atrial
fibrillation during the follow-up period: patients with atrial
fibrillation prior to mitral valve surgery (Tables 8 and 9)
Increased left atrial diameter (P = 0.05) and increased
posterior left ventricular wall thickness (P = 0.05) predicted
independently episodes of atrial fibrillation late after mitral
valve repair. A history of preoperative antiarrhythmic drug
treatment, increased cardiopulmonary bypass time or older
age at operation were univariate predictors only.
3.5. Atrial fibrillation-index
For patients who were in chronic or intermittent atrial
Table 2
Logistic regression: univariate analysis: all patients
Odds ratio 95% CL P-value
Preop. chronic AF 20.9 7.7–56 0.0001
Preop. intermittent AF 5.08 2.0–12.5 0.0005
Age at operation/year 1.05 1.02–1.07 0.001
Preop. antiarr. therapy 3.14 1.6–5.9 0.001
Preop. digoxin 2.98 1.5–5.7 0.001
LVEF/% 0.96 0.93–0.99 0.005
Duration AF/months 1.04 1.0–1.07 0.005
Heart rate/min 1.03 1.0–1.05 0.01
LVESD/cm 1.78 1.18–2.69 0.01
Left atrial diameter/cm 1.47 1.07–2.02 0.05
CL, confidence limits; preop, preoperative; AF,:atrial fibrillation; antiarr.,
antiarrhythmic; LVEF, left ventricular ejection fraction; LVESD, left ven-
tricular end-systolic diameter.
Table 3
Logistic regression: multivariate analysis: all patients
Odds ratio 95% CL P-value
Preop. chronic AF 17.7 5.5–57.5 0.0001
Preop. intermittent AF 6.29 2.25–17.6 0.0005
Age/year 1.05 1.01–1.09 0.005
Heart rate/min 1.03 1.0–1.06 0.05
CL, confidence limits; preop., preoperative; AF, atrial fibrillation.
Table 4
Logistic regression: univariate analysis: patients with atrial fibrillation
prior to mitral valve surgery
Odds ratio 95% CL P-value
Age/year 1.09 1.04–1.14 0.001
Preop. antiarrhythmic drugs 4.40 1.38–14.03 0.01
PAP diastolic/mmHg 1.23 1.05–1.44 0.01
LV posterior wall/mm 1.96 1.2–3.21 0.01
Heart rate/min 1.04 1.0–1.08 0.05
PAP systolic/mmHg 1.10 1.01–1.2 0.05
PAP mean/mmHg 1.14 1.02–1.28 0.05
Intermittent. vs. chronic AF 0.24 0.08–0.77 0.05
CL, confidence limits; preop., preoperative; PAP, pulmonary artery pres-
sure; LV, left ventricular.
Table 5
Log. regression: multivariate analysis: patients with atrial fibrillation prior
to mitral valve surgery
Odds ratio 95% CL P-value
PAP mean/mmHg 1.21 1.04–1.4 0.05
Age/year 1.06 1.0–1.13 0.05
Intermittent vs. chronic AF 8.35 15–46.7 0.05
CL, confidence limits; PAP, pulmonary artery pressure.
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fibrillation prior to mitral valve repair, combined cut-off
points, called the ‘atrial fibrillation index’, were found, pre-
dicting the presence of atrial fibrillation late after successful
mitral valve reconstruction: age at operation . 57.5 years
(1 point), mean pulmonary artery pressure ‡ 15 mmHg (1
point) or mean pulmonary artery pressure ‡ 23 mmHg (2
points), and a history of antiarrhythmic drug treatment (1
point) were found to be significant predictors for late atrial
fibrillation. The presence of .3 points predicted late atrial
fibrillation with a specificity of 92.3% and a sensitivity of
77.6%. Although its negative predictive value was only
52.2%, .3 points had a positive predictive value of
97.4% and an odds ratio of 41.45 (95% confidence limits
4.84–355.00) and this was highly significant (P , 0.0001).
For patients .57.5 years having a mean pulmonary artery
pressure ‡ 23 mmHg prior to mitral valve repair (that is .3
points from age and mean pulmonary artery pressure only),
the sensitivity and specificity for the presence of late atrial
fibrillation was 81.6%, respectively, 92.3% with a positive
predictive value off 97.6% and a negative predictive value
of 57.1%. In these patients, the atrial fibrillation index had
an odds ratio of 53.33 (95% confidence limits 6.12–464.48
and this was highly significant (P , 0.0001).
3.6. Operative technique
Increased cardiopulmonary bypass time was an univari-
ate predictor for episodes of atrial fibrillation (P = 0.05) late
after successful mitral valve repair. A cut-off point was not
found. Neither aortic cross clamp time, mitral valve pathol-
ogy nor specified techniques of mitral valve repair were
found to predict postoperative heart rhythm.
4. Discussion
The strong cerebrovascular risk of chronic atrial fibrilla-
tion cannot be adequately eliminated by conventional treat-
ment such as long-term oral anticoagulation, electrical- and/
or drug-induced conversion, drug-induced ventricular rate-
control or catheter ablation technique [10–12]. Despite the
decline of the incidence of rheumatic heart disease, mitral
stenosis and mitral insufficiency are commonly associated
with atrial fibrillation and systemic embolism. Up to 80% of
patients with chronic atrial fibrillation before surgery
remained in atrial fibrillation even after an otherwise suc-
cessful mitral valve repair [4]. Thus, in patients undergoing
mitral valve reconstruction, simultaneous elimination of the
arrhythmia is desirable to prevent antiarrhythmic treatment
and long-term anticoagulation as well as continuing atrial
enlargement as the consequence of chronic atrial fibrillation
[13]. Therefore, surgery for atrial fibrillation has been suc-
cessfully combined with mitral valve surgery by several
groups [4,5,14]. Kosakai proposed that every patient with
atrial fibrillation undergoing mitral valve surgery should be
considered for the combined maze procedure [15].
However, performing combined surgery for atrial fibrilla-
tion, e.g. the maze operation, an average cross-clamping
time of 48–70 min is required [3,14] as compared with
the valvular procedures alone, implying an additional bur-
den on the heart. In addition, delayed sinus node function
recovery [16], dual-chamber pacemaker implantation in up
to 40% of patients [3], attenuated sinoatrial node response to
exercise [6] and temporary loss of cardiac autonomic inner-
vation [7] are described after atrial surgery. Thus, the indi-
cation to combine surgery for atrial fibrillation with mitral
Table 6
Cox regression: univariate analysis: all patients
Hazard-ratio 95% CL P-value
Lack of preop. SR 5.98 3.7–9.64 0.0001
Duration AF/months 1.01 1.00–1.01 0.0001
Left atrial diameter/cm 1.52 1.2–1.92 0.0005
Digoxin 2.25 1.44–3.51 0.0005
LVESD/cm 1.56 1.2–2.04 0.005
LVEF/% 0.97 0.96–0.99 0.005
Age/year 1.03 1.02–1.05 0.005
CL, confidence limits; preop., preoperative; LVESD, left ventricular end-
systolic diameter; LVEF, left ventricular ejection fraction; AF, atrial fi-
brillation.
Table 7
Cox regression: multivariate analysis: all patients
Hazard-ratio 95% CL P-value
Lack of preoperative SR 4.72 2.8–7.95 0.0001
Left atrial diameter/cm 1.48 1.16–1.89 0.005
LVEF >60% 0.28 0.11–0.72 0.01
Age/year 1.02 1.00–1.04 0.05
CL, confidence limits; LFEV, left ventricular ejection fraction.
Table 8
Cox regression: univariate analysis: patients with atrial fibrillation prior to
mitral valve surgery
Hazard-ratio 95% CL P-value
Preop. antiarr. drugs 1.91 1.04–3.48 0.05
Left atrial diameter/cm 1.34 1.03–1.76 0.05
LV posterior wall/mm 1.19 1.01–1.40 0.05
CPB time/min 1.01 1.00–1.02 0.05
Age/year 1.03 1.01–1.05 0.05
CL, confidence limits; preop., preoperative; antiarr., antiarrhythmic; LV,
left ventricular.
Table 9
Cox regression: multivariate analysis: patients with atrial fibrillation prior
to mitral valve surgery
Hazard-ratio 95% CL P-value
LA diameter/cm 1.41 1.07–1.86 0.05
LV posterior wall/mm 1.21 1.03–1.42 0.05
CPB time/min 1.01 1.00–1.02 0.055
CL, confidence limits; LA, left atrial; LV, left ventricular; CPB, cardio-
pulmonary.
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valve repair should be based on careful identification of
patients who will likely benefit from a more extended sur-
gical approach.
The aim of this study was to identify preoperative vari-
ables that would accurately predict the presence of atrial
fibrillation late after successful mitral valve repair in
patients with preoperative atrial fibrillation and in those
who were in sinus rhythm prior to surgery. The presence
of preoperative chronic or intermittent atrial fibrillation,
increased heart rate, older age at operation and increased
mean pulmonary artery pressure were the strongest predic-
tors for atrial fibrillation late after mitral valve reconstruc-
tion. Longer duration of atrial fibrillation prior to surgery,
increased left atrial diameter and reduced left ventricular
function were not found to be independent predictors for
late atrial fibrillation. This is surprising, as in Kosakai’s
study, a larger left atrial dimension and a longer time of
preoperative atrial fibrillation failed to restore sinus rhythm
after successful mitral valve repair combined with the maze
procedure [15].
Although of low prevalence in this study, cardiovascular
risk factors commonly associated with an increased inci-
dence of atrial fibrillation, such as arterial hypertension or
coronary artery disease were not found to be important vari-
ables in this study predicting late atrial fibrillation.
Predictors for episodes of atrial fibrillation during the
follow-up period irrespective of the heart rhythm observed
at the end of the follow-up were similar and were the same
for all patients regardless whether they were in preoperative
sinus rhythm or atrial fibrillation. Again, older age as well as
intermittent atrial fibrillation have found to be independent
risk factors for chronic or intermittent atrial fibrillation late
after mitral valve repair. Thus, surgery for atrial fibrillation
presumably should not be restricted to patients with chronic
arrhythmias who are young and would be expected to have
the long term risks of anticoagulation and antiarrhythmic
drug treatment as suggested by Chua et al. [4].
Based on our data, we were able to create a simple atrial
fibrillation index for age at operation, mean pulmonary
artery pressure and a history of antiarrhythmic drug treat-
ment allowing us to identify those patients with the highest
probability to be in atrial fibrillation late after mitral valve
repair. Interestingly, in this study, it was not possible to
define a specific duration of atrial fibrillation prior to mitral
valve surgery, e.g. like recent onset atrial fibrillation [15] or
atrial fibrillation lasting for 1 year prior to mitral valve
surgery [17], advocating combined surgery for atrial fibril-
lation.
There are several limitations of our study: first, it is a
retrospective analysis, based on echocardiographic findings
obtained 15–20 years ago; second, left ventricular dimen-
sions, measured by echocardiography, were available in
only 80% of patients; third, 15% of patients were lost to
follow-up; fourth, improvements in operative technique
during the study period, such as the introduction of blood
or combined antegrade-retrograde cardioplegia may have
had an impact on the presence of atrial fibrillation late
after mitral valve surgery; fifth, results of the Cox regres-
sion are thought to be less reliable in that it is almost
impossible to detect all episodes of atrial fibrillation during
a long-term follow-up after mitral valve repair. Neverthe-
less, predictors found with Cox regression were similar to
those obtained by linear regression. The risk of occurrence
of atrial fibrillation over time after successful mitral valve
reconstruction – a kind of an actuarial survival curve of the
sinus rhythm after successful mitral valve repair – has not
been addressed, because it was not possible to define pre-
cisely the exact onset of atrial fibrillation during the follow-
up time.
In conclusion, the present study indicates that older
patients with chronic or intermittent atrial fibrillation, a his-
tory of antiarrhythmic drug treatment and an elevated mean
pulmonary artery pressure are at a substantial risk for recur-
rent atrial fibrillation late after successful mitral valve
reconstruction. In these patients, mitral valve repair could
be combined with surgery for atrial fibrillation even though
sinus rhythm is present preoperatively. In addition, an
increased preoperative heart rate, an enlarged left atrium,
a decreased left ventricular function and an increased thick-
ness of the posterior left ventricular wall function support
the assumption to combine mitral valve repair with surgery
for atrial fibrillation.
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Appendix A. Conference discussion
Dr J. Melo (Carnaxide, Portugal): I think this is a very important paper
regarding all the problems related with atrial fibrillation and surgical pro-
cedures. Looking at your conclusions, you are advising prophylactic maze
operation. I have difficulty understanding the recommendation for prophy-
lactic maze operation on that setting of patients because the maze opera-
tion is a risky operation. So in your experience, what is the risk of the maze
operation concomitant with mitral valve surgery in order that you are able
to recommend the concomitant procedures?
Dr Vogt: We combined maze and mitral valve surgery in about 25
patients so far. We have seen an increased aortic cross clamp and cardi-
opulmonary bypass time. The mean increase in aortic cross clamp time
was 48 min. After the combined maze operation, patients were 1 or 2 days
longer on the intensive care station compared to isolated mitral valve
repair. An increased incidence of pacemaker implantation, as reported
by Cox, has not been observed in our patients. In our opinion, the maze
operation can safely be combined with mitral valve repair.
Dr Melo: In every patient? Do you think there are limitations for those
indications? I agree that there are strong indications to add the procedure,
but I don’t see reasons to accept these recommendations as a general rule.
So what would be the limitation of this general recommendation?
Dr Vogt: The absence of these independent predictors late atrial fibril-
lation as presented. I think in patients with chronic atrial fibrillation for 1
year or some months only, or in those with intermittent atrial fibrillation or
with a history of antiarrhythmic treatment, to combine maze and mitral
valve repair is not prophylactic. Even though patients are in sinus rhythm
prior to surgery, they suffered from atrial fibrillation which may return and
persist postoperatively. As we have seen in our retrospective study, atrial
fibrillation can occur again late after mitral valve repair. After successful
mitral valve repair, the advantage to be free from anticoagulation will be
denied by the onset of atrial fibrillation. I think in patients who present
these strong predictors, who had a history of atrial fibrillation or a mean
pulmonary artery pressure .25 mmHg the combined maze is not a pro-
phylactic operation. It is a safe operation and we would recommend it.
Dr A. Moritz (Frankfurt, Germany): There are people now suggesting
mini-maze procedures dealing only with the left atrium or encircling pul-
monary veins. Do you, from your data, have any indications that atrial
fibrillation in your patients originates from the left or the right atrium? If
the pulmonary artery pressure is one predictive factor, also the right
atrium? If the pulmonary artery pressure is one predictive factor, should
be involved in the origin or etiology or the atrial fibrillation. Do you have
any data on this?
Dr Vogt: We have performed operations using the mini-maze techni-
que, but we were not happy with this technique because patients remained
in chronic atrial fibrillation postoperatively. I know there are papers who
tell us that if the pathology is in the left atrium, like in mitral valve
regurgitation, one can do only a so called left-sided maze. As Cox men-
tioned most of the newer techniques trying to minimise the maze operation
are not tested electrophysiologically. I think we should be careful to use
simpler, alternative maze techniques. As I said, we were not pleased with
the mini-maze.
Dr Moritz: Well, If you suggest to do a maze procedure prophylacti-
cally this would be maybe a trade-off of decreasing the operative risk. In
other words, we have a few patients where we did a simple right maze for
ASDs or tricuspid incompetence and that worked quite nice.
Dr Vogt: As I said, we don’t find that it’s just prophylactically. We feel
it safe to combine the maze with other operations. We would continue
recommend the advanced maze III.
Dr Melo: If you have a calcified left atrium, or if you have a 60-year-
old patient with a general condition incompatible with a long bypass,
atrium, or if you general condition would you still advise this combination
or procedures?
Dr Vogt: No, I think if there are additional factors that would increase
perioperative risk, if left ventricular function is worse, if there is a left
atrium more than 7 cm in diameter, as described by Kosakai we would
hesitate to perform an additional maze, that’s true. But I think for each
patient the decision to do a maze or not has to be individualized.
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